Recently, Beijing Kelian Shenghua Medical Technology Co., Ltd., relying on its technological and patent innovation capabilities in the field of disposable analgesic infusion devices, has successfully passed preliminary examination, formal review, and expert evaluation, and has been recognized as a "Beijing Intellectual Property Pilot Unit" and has been awarded the "Intellectual Property Pilot Unit Certificate" by the Beijing Intellectual Property Office.

As a pioneer in the anesthesia and analgesic industry in China, Beijing Kelian Shenghua has always adhered to various business norms and legal norms, respected the intellectual property rights of others, and highly valued the research and protection of intellectual property rights. The company was established in 1993, and the "Shenghua" brand series of products obtained national patents in the same year. Since then, it has actively carried out patent layout and achieved steady accumulation of patent assets.

This successful selection not only confirms the strong research and development strength of Kelian Shenghua by the intellectual property regulatory department, but also highlights the deep accumulation of Kelian Shenghua in patent technology. We will take this opportunity to continuously improve the strength of our company's research and development innovation and intellectual property management protection, enhance our core competitiveness, and push Kelian Sublimation to a new height in the anesthesia and analgesic industry.